Search for stock quotes, financial statistics and more
Following the release of new preclinical data, Leede Jones Gable analyst Douglas Loe remains upbeat ... Read More
Following news from the company, Leede Jones Gable analyst Douglas Loe remains bullish about Cardiol... Read More
The stock may be down considerably over the past year and a half, but investors can expect better ti... Read More
Leede Jones Gable analyst Douglas W. Loe provided an update to clients on Monday on Canadian cardiov... Read More
With the news of a discontinued clinical trial from Cardiol Therapeutics (Cardiol Therapeutics Stock... Read More
Share
Tweet
pin
Share